CYREN (CYRN) Misses Q1 EPS by 2c

CYREN (NASDAQ: CYRN) reported Q1 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $7.39 million.

Cash as of March 31, 2016 was $14.0 million, compared to $16.4 million as of December 31, 2015. During the quarter, CYREN paid down in full and terminated its line of credit, ending the quarter with no debt.

For earnings history and earnings-related data on CYREN (CYRN) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Erasca, Inc. (ERAS) Misses Q2 EPS by 3c
• Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c